SacredBod
0
R-Alpha Lipoic Acid Pure — SacredBod supplement bottle (illustrative)
Supplement · Neuropathy & Glucose Transport

R-Alpha Lipoic Acid Pure

300 mg · vegan · gluten-free · 60 caps

Diabetic neuropathyBurning feetTingling and numbnessHigh blood sugarOxidative stress NervesBrainLiverMusclesHeart
BUY on Amazon →

Affiliate link · we earn from qualifying purchases. No paid placements.

Overview Stacks Timing Related Research FAQs

What it is

Alpha-lipoic acid (ALA) is a powerful antioxidant that is both water-soluble and fat-soluble, allowing it to work in every cell compartment. Commercial ALA supplements contain a 50:50 mixture of R- and S- isomers, but only the R-isomer is biologically active and naturally produced by the body. R-ALA is approximately 12 times more potent than the racemic mixture, providing superior bioavailability and therapeutic effects at lower doses. It is the form used in the landmark SYDNEY trials for diabetic neuropathy.

How it works

R-ALA scavenges free radicals directly, regenerates other antioxidants (vitamin C, vitamin E, glutathione), and chelates heavy metals. In diabetes, it improves nerve blood flow by enhancing nitric oxide-mediated vasodilation, reduces oxidative stress in peripheral nerves, and increases glucose uptake into cells through AMPK activation and GLUT4 translocation. The R-isomer specifically binds to mitochondrial enzymes (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase) that are impaired in diabetes, restoring energy metabolism.

Who should take it

Individuals with diabetic peripheral neuropathy (burning, tingling, numbness), those with prediabetes or Type 2 diabetes seeking glucose transport support, people wanting mitochondrial antioxidant protection, and individuals with heavy metal exposure. Highly relevant for India — 50% of diabetics develop neuropathy, and R-ALA is one of the few proven treatments.

Avoid / careful

People with thiamine (vitamin B1) deficiency (ALA may compete with thiamine), those on thyroid medication without monitoring (may affect thyroid hormone levels), individuals with severe liver disease, pregnant or breastfeeding women. Side effects: Very safe at 300–600 mg/day. Rarely: mild nausea, stomach upset, or skin rash at high doses. May cause hypoglycemia in sensitive individuals when combined with diabetes medication. The R-isomer produces fewer side effects than racemic ALA.

When to take it

Morning
Noon
Evening
Night

How to take it

With food
Empty stomach
Before food

FAQs

Frequently asked

How long before I see neuropathy results?
The SYDNEY 2 trial showed significant symptom improvement within 5 weeks at 600 mg/day. The SYDNEY IV trial showed even faster results — significant pain reduction within 3 weeks of IV administration. For oral R-ALA, expect 2–4 weeks for symptom relief and 3–6 months for nerve function improvement.
Is R-ALA better than regular ALA?
Yes. R-ALA is the naturally occurring, biologically active isomer. Racemic ALA contains 50% inactive S-ALA that the body cannot use and must eliminate. R-ALA provides approximately 12x the potency per milligram and produces fewer side effects. It is the form used in European prescription products.
Can I take it with my neuropathy medication?
Yes. R-ALA complements pregabalin, gabapentin, and duloxetine by addressing the root cause (oxidative stress and nerve ischemia) rather than just masking symptoms. The German medical system reimburses ALA for diabetic neuropathy. Inform your doctor of all supplements.

In plain English

A plain-English read of the literature behind this supplement. Not a clinical recommendation.

Key citations: PMID 12610036 (SYDNEY trial — IV ALA improves neuropathic symptoms, 2003), PMID 17065669 (SYDNEY 2 trial — oral ALA 600 mg optimal dose, 2006), PMC3272801 (Meta-analysis of RCTs — TSS reduction of 2.26 points, 2011)

Editorial notes

SacredBod's longer take on R-Alpha Lipoic Acid Pure — context the structured blocks above don't capture.

R-Alpha Lipoic Acid is the most clinically validated natural treatment for diabetic neuropathy — a condition that affects 50% of all diabetics and for which conventional medicine offers only symptom masking (pregabalin, gabapentin) rather than root-cause treatment. The SYDNEY trials, conducted across Russia, Israel, and Germany, proved that ALA not only relieves neuropathic pain but actually improves nerve physiology.

What the Research Shows

The SYDNEY trial (PMID 12610036) randomised 120 diabetic patients to IV ALA 600 mg or placebo for 3 weeks. The ALA group showed a dramatic 5.7-point improvement in Total Symptom Score (pain, burning, numbness, tingling) compared to just 1.8 points in the placebo group. Nerve conduction improved, and the effect was attributed to restored nerve pathophysiology — not just symptom masking.

The SYDNEY 2 trial (PMID 17065669) tested oral ALA at 600 mg, 1200 mg, and 1800 mg daily for 5 weeks in 181 patients. All doses significantly improved neuropathic symptoms, but 600 mg provided the optimal risk-to-benefit ratio — 51% symptom reduction with minimal side effects. Higher doses caused more nausea and vertigo without additional benefit.

A 2011 meta-analysis (PMC3272801) pooled all RCTs and found a standardized mean difference of -2.26 in TSS scores favouring ALA — a clinically meaningful improvement. Intravenous ALA at 600 mg/day for 3 weeks received Grade A recommendation for neuropathic pain relief.

India Context

  • Availability: Reverse Clinics, Pure Nutrition, HealthyHey, Nature’s Move, and Carbamide Forte offer ALA capsules (300–600 mg) on Amazon India. Most products are racemic ALA; pure R-ALA is harder to find and more expensive.
  • Price: ₹400–₹1,000 for 60–120 capsules (300 mg)
  • Neuropathy crisis: India has 77 million diabetics, and diabetic neuropathy is the most common complication. Many Indian patients suffer in silence, assuming burning feet and numbness are “just part of diabetes.” ALA offers evidence-based hope.
  • German precedent: In Germany, ALA is reimbursed by health insurance for diabetic neuropathy — a recognition of its clinical value that Indian healthcare systems have yet to adopt.
  • Ayurvedic parallel: While not native to Ayurveda, ALA’s nerve-protective and antioxidant effects align with Ashwagandha (Withania somnifera) and Brahmi (Bacopa monnieri) as nervine tonics.

Dosage & Safety

  • Standard dose: 300 mg R-ALA daily with meals (equivalent to ~600 mg racemic)
  • Neuropathy protocol: 600 mg R-ALA daily (or 600 mg racemic)
  • Best time: Morning with breakfast
  • Caution: May enhance diabetes medication effects — monitor blood sugar. Separate from thyroid medication by 4 hours. Those with thiamine deficiency should supplement B1 simultaneously.
Added to your stack.